R&D News | pharmaphorum

News

Seattle Genetics and Astellas gain Breakthrough Designation ...

The FDA has granted Breakthrough Therapy Designation to enfortumab vedotin, an antibody-drug conjugate (ADC) being developed by Seattle Genetics and Astellas.

Market Access

Verona to take COPD hopeful into phase 3

Verona Pharma is to take lung drug RPL554 into late clinical development after a successful phase 2b trial.

Digital

Mitsubishi and Hitachi to use AI to hasten drug R&D

Mitsubishi Tanabe Pharma and Hitachi have become the latest companies attempting to use artificial intelligence (AI) to more efficiently develop drugs.

News